Correction to: Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry.
作者信息
Hu Cheng, Wang Tao, Zhuang Xiaoyu, Sun Qiaoli, Wang Xiaochun, Lin Hui, Feng Mingli, Zhang Jiaqi, Cao Qin, Jiang Yuanye
机构信息
Experiment Center for Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Department of Gastroenterology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, 164 Lanxi Road, Shanghai, 200062, China.
出版信息
J Transl Med. 2022 Jan 10;20(1):24. doi: 10.1186/s12967-021-03223-4.
Abstract
摘要
相似文献
1
Correction to: Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry.
J Transl Med. 2022 Jan 10;20(1):24. doi: 10.1186/s12967-021-03223-4.
2
Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease.
Gastroenterology. 2014 Jan;146(1):46-62. doi: 10.1053/j.gastro.2013.11.001. Epub 2013 Nov 7.
3
Liquid Extraction Surface Analysis Mass Spectrometry Method for Identifying the Presence and Severity of Nonalcoholic Fatty Liver Disease.
Anal Chem. 2017 May 2;89(9):5161-5170. doi: 10.1021/acs.analchem.7b01097. Epub 2017 Apr 19.
4
Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry.
J Transl Med. 2021 Apr 15;19(1):152. doi: 10.1186/s12967-021-02820-7.
5
Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.
J Proteome Res. 2010 Sep 3;9(9):4501-12. doi: 10.1021/pr1002593.
6
Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population.
PLoS One. 2019 Nov 4;14(11):e0224626. doi: 10.1371/journal.pone.0224626. eCollection 2019.
7
Moderation Effect of Handgrip Strength on the Associations of Obesity and Metabolic Syndrome With Fatty Liver in Adolescents.
J Clin Densitom. 2020 Apr-Jun;23(2):278-285. doi: 10.1016/j.jocd.2019.04.003. Epub 2019 Apr 11.
8
The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
Turk J Gastroenterol. 2014 Dec;25 Suppl 1:63-8. doi: 10.5152/tjg.2014.6233.
9
Distinguishing NASH Histological Severity Using a Multiplatform Metabolomics Approach.
Metabolites. 2020 Apr 24;10(4):168. doi: 10.3390/metabo10040168.
10
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
Ann Intern Med. 2005 Nov 15;143(10):722-8. doi: 10.7326/0003-4819-143-10-200511150-00009.
引用本文的文献
1
Biomarker discovery in NAFLD: insights from metabolomics and vote counting meta-analysis.
Metabolomics. 2025 Aug 12;21(5):116. doi: 10.1007/s11306-025-02312-5.
本文引用的文献
1
Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry.
J Transl Med. 2021 Apr 15;19(1):152. doi: 10.1186/s12967-021-02820-7.
Zotero 插件